LEPR and breast cancer: It has in fact been shown in MCF7, MDA-231 and MDA-468 breast cancer cells that treatment with leptin can phosphorylate IGF1R and activate downstream signaling while treatment with IGF1 phosphorylates leptin receptor and activates downstream signaling [27].